Skip to main content
SpringerLink
Log in

Combination Therapies for Choroidal Neovascularization

  • Chapter
Medical Retina

Part of the book series: Essentials in Ophthalmology ((ESSENTIALS))

  • 968 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.00
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abramsson A, Lindblom P, Betsholtz C (2003) Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors. J Clin Invest 112:1142–1151

    Article  PubMed  CAS  Google Scholar 

  2. Abdollahi A, Lipson KE, Sckell A et al (2003) Combined therapy with direct and indirect angiogenesis inhibition results in enhanced antiangiogenic and antitumor effects. Cancer Res 63(24):8890–8898

    PubMed  CAS  Google Scholar 

  3. Abdollahi A, Li M, Ping G, Plathow C et al (2005) Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis. J Exp Med 201:925–935

    Article  PubMed  CAS  Google Scholar 

  4. Ahmed J, Braun RD, Dunn R, Linsenmeier RA (1993) Oxygen distribution in the macaque retina. Invest Ophthalmol Vis Sci 34:516–521

    PubMed  CAS  Google Scholar 

  5. Apte RS, Barreiro RA, Duh E et al (2004) Stimulation of neovascularization by the anti-angiogenic factor PEDF. Invest Ophthalmol Vis Sci 45:4491–4497

    Article  PubMed  Google Scholar 

  6. Arias L, Garcia-Arumi J, Ramon JM et al (2006) Photodynamic therapy with intravitreal triamcinolone in predominantly classic choroidal neovascularization one-year results of a randomized study. Ophthalmology 84(6):743–748

    Google Scholar 

  7. Arnold JJ, Blinder KJ, Bressler NM et al (2004) Acute severe visual acuity decrease after photodynamic therapy with verteporfin: case reports from randomized clinical trials-TAP and VIP report no. 3. Am J Ophthalmol 137:683–696

    Article  PubMed  CAS  Google Scholar 

  8. Asahara T, Masuda H, Takahashi T et al (1999) Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85:221–228

    PubMed  CAS  Google Scholar 

  9. Augustin AJ, Schmidt-Erfurth U (2006) Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult choroidal neovascularization in age-related macular degeneration. Am J Ophthalmol 141:638–645

    Article  PubMed  CAS  Google Scholar 

  10. Bergers G, Song S, Meyer-Morse N, Bergsland E, Hanahan D (2003) Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J Clin Invest 111:1287–1295

    Article  PubMed  CAS  Google Scholar 

  11. Bhutto IA, McLeod DS, Hasegawa T et al (2006) Pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in aged human choroid and eyes with age-related macular degeneration. Exp Eye Res 82:99–110

    Article  PubMed  CAS  Google Scholar 

  12. Boussat S, Eddahibi S, Coste A et al (2000) Expression and regulation of vascular endothelial growth factor in human pulmonary epithelial cells. Am J Physiol Lung Cell Mol Physiol 279: L371–L378

    PubMed  CAS  Google Scholar 

  13. Brieger J, Schroeder P, Gosepath J, Mann WJ (2005) VEGF-subtype specific protection of SCC and HUVECs from radiation induced cell death. Int J Mol Med 15(1):145–151

    PubMed  CAS  Google Scholar 

  14. Brown DM, Kaiser PK, Michels M et al (2006) Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 355:1432–1444

    Article  PubMed  CAS  Google Scholar 

  15. Canalis E (1981) Effect of platelet-derived growth factor on DNA and protein synthesis in cultured rat calvaria. Metabolism 30:970–975

    Article  PubMed  CAS  Google Scholar 

  16. Carmeliet P, Jain RK (2000) Angiogenesis in cancer and other diseases. Nature 407:249–257

    Article  PubMed  CAS  Google Scholar 

  17. Carswell EA, Old LJ, Kassel RL et al (1975) An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 72:3666–3670

    Article  PubMed  CAS  Google Scholar 

  18. Chan WM, Lai TY, Wong AL et al (2006) Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of subfoveal choroidal neovascularisation in age related macular degeneration: a comparative study. Br J Ophthalmol 90:337–341

    Article  PubMed  Google Scholar 

  19. Cursiefen C, Chen L, Borges LP et al (2004) VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J Clin Invest 113:1040–1050

    Article  PubMed  CAS  Google Scholar 

  20. Darland DC, Massingham LJ, Smith SR et al (2003) Pericyte production of cell-associated VEGF is differentiation-dependent and is associated with endothelial survival. Dev Biol 264:275–288

    Article  PubMed  CAS  Google Scholar 

  21. Duh EJ, Yang HS, Haller JA et al (2004) Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor: implications for ocular angiogenesis. Am J Ophthalmol 137:668–674

    Article  PubMed  CAS  Google Scholar 

  22. Dvorak HF, Brown LF, Detmar M, Dvorak AM (1995) Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146:1029–1039

    PubMed  CAS  Google Scholar 

  23. Erber R, Thurnher A, Katsen AD et al (2004) Combined inhibition of VEGF and PDGF signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms. FASEB J 18:338–340

    PubMed  CAS  Google Scholar 

  24. Ergun E, Maar N, Ansari-Shahrezaei S et al (2006) Photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide in the treatment of neovascular age-related macular degeneration. Am J Ophthalmol 142:10–16

    Article  PubMed  CAS  Google Scholar 

  25. Espinosa-Heidmann DG, Suner IJ, Hernandez EP et al (2003) Macrophage depletion diminishes lesion size and severity in experimental choroidal neovascularization. Invest Ophthalmol Vis Sci 44:3586–3592

    Article  PubMed  Google Scholar 

  26. Espinosa-Heidmann DG, Reinoso MA, Pina Y et al (2005) Quantitative enumeration of vascular smooth muscle cells and endothelial cells derived from bone marrow precursors in experimental choroidal neovascularization. Exp Eye Res 80:369–378

    Article  PubMed  CAS  Google Scholar 

  27. Fackler TK, Reddy S, Bearelly S et al (2006) Retrospective review of eyes with neovascular age-related macular degeneration treated with photodynamic therapy with verteporfin and intravitreal triamcinolone. Ann Acad Med Singapore 35:701–705

    PubMed  Google Scholar 

  28. Ferrara N, Hillan KJ, Novotny W (2005) Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy. Biochem Biophys Res Commun 333:328–335

    Article  PubMed  CAS  Google Scholar 

  29. Freund KB, Klais CM, Eandi CM et al (2006) Sequenced combined intravitreal triamcinolone and indocyanine green angiography-guided photodynamic therapy for retinal angiomatous proliferation. Arch Ophthalmol 124:487–492

    Article  PubMed  CAS  Google Scholar 

  30. Gasparini G, Longo R, Fanelli M, Teicher BA (2005) Combination of antiangiogenic therapy with other anticancer therapies: results, challenges, and open questions. J Clin Oncol 23:1295–1311

    Article  PubMed  CAS  Google Scholar 

  31. Gragoudas ES, Adamis AP, Cunningham ET Jr et al (2004) Pegaptanib for neovascular agerelated macular degeneration. N Engl J Med 351:2805–2816

    Article  PubMed  CAS  Google Scholar 

  32. Grossniklaus HE, Green WR (2004) Choroidal neovascularization. Am J Ophthalmol 137:496–503

    Article  PubMed  Google Scholar 

  33. Grossniklaus HE, Ling JX, Wallace TM et al (2002) Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization. Mol Vis 8:119–126

    PubMed  CAS  Google Scholar 

  34. Guo P, Hu B, Gu W et al (2003) Platelet-derived growth factor-B enhances glioma angiogenesis by stimulating vascular endothelial growth factor expression in tumor endothelia and by promoting pericyte recruitment. Am J Pathol 162:1083–1093

    PubMed  CAS  Google Scholar 

  35. Gupta VK, Jaskowiak NT, Beckett MA et al (2002) Vascular endothelial growth factor enhances endothelial cell survival and tumor radioresistance. Cancer J 8:47–54

    PubMed  Google Scholar 

  36. Hampton T (2005) Monoclonal antibody therapies shine in breast cancer clinical trials. JAMA 293:2985–2989

    Article  PubMed  CAS  Google Scholar 

  37. Heier JS, Boyer DS, Ciulla TA et al (2006) Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration: year 1 results of the FOCUS Study. Arch Ophthalmol 124:1532–1542

    Article  PubMed  CAS  Google Scholar 

  38. Heldin CH, Westermark B (1999) Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 79:1283–1316

    PubMed  CAS  Google Scholar 

  39. Hirschi KK, Rohovsky SA, Beck LH, Smith SR, D’Amore PA (1999) Endothelial cells modulate the proliferation of mural cell precursors via platelet-derived growth factor-BB and heterotypic cell contact. Circ Res 84:298–305

    PubMed  CAS  Google Scholar 

  40. Holekamp NM, Bouck N, Volpert O (2002) Pigment epithelium-derived factor is deficient in the vitreous of patients with choroidal neovascularization due to age-related macular degeneration. Am J Ophthalmol 134:220–227

    Article  PubMed  CAS  Google Scholar 

  41. Hori K, Saito S, Tamai M (2004) Effect of irradiation on neovascularization in rat skinfold chambers: implications for clinical trials of lowdose radiotherapy for wet-type age-related macular degeneration. Int J Radiat Oncol Biol Phys 60:1564–1571

    Article  PubMed  Google Scholar 

  42. Hurwitz H, Fehrenbacher L, Novotny W et al (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350:2335–2342

    Article  PubMed  CAS  Google Scholar 

  43. Husby G, Williams RC Jr (1988) Synovial localization of tumor necrosis factor in patients with rheumatoid arthritis. J Autoimmun 1:363–371

    Article  PubMed  CAS  Google Scholar 

  44. Jain RK (2005) Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307:58–62

    Article  PubMed  CAS  Google Scholar 

  45. Kamiyama K, Iguchi I, Wang X, Imanishi J (1998) Effects of PDGF on the migration of rabbit corneal fibroblasts and epithelial cells. Cornea 17:315–325

    Article  PubMed  CAS  Google Scholar 

  46. Kent D, Sheridan C (2003) Choroidal neovascularization: a wound healing perspective. Mol Vis 9:747–755

    PubMed  CAS  Google Scholar 

  47. Kermani P, Leclerc G, Martel R, Fareh J (2001) Effect of ionizing radiation on thymidine uptake, differentiation, and VEGFR2 receptor expression in endothelial cells: the role of VEGF(165). Int J Radiat Oncol Biol Phys 50(1):213–220

    Article  PubMed  CAS  Google Scholar 

  48. Killingsworth MC (1995) Angiogenesis in early choroidal neovascularization secondary to agerelated macular degeneration. Graefes Arch Clin Exp Ophthalmol 233:313–323

    Article  PubMed  CAS  Google Scholar 

  49. Kim KJ, Li B, Winer J et al (1993) Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362:841–844

    Article  PubMed  CAS  Google Scholar 

  50. Krebs I, Binder S, Stolba U (2006) A new treatment regimen in combined intravitreal injection of triamcinolone acetonide and photodynamic therapy. Graefes Arch Clin Exp Ophthalmol 244:863–867

    Article  PubMed  CAS  Google Scholar 

  51. Krettek A, Ostergren-Lunden G, Fager G et al (2001) Expression of PDGF receptors and ligandinduced migration of partially differentiated human monocyte-derived macrophages. Influence of IFN-gamma and TGF-beta. Atherosclerosis 156:267–275

    Article  PubMed  CAS  Google Scholar 

  52. Lindblom P, Gerhardt H, Liebner S et al (2003) Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall. Genes Dev 17:1835–1840

    Article  PubMed  CAS  Google Scholar 

  53. Lyden D, Hattori K, Dias S et al (2001) Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med. 2001 (11):1194–1201

    Article  CAS  Google Scholar 

  54. McColm JR, Geisen P, Hartnett ME. VEGF isoforms and their expression after a single episode of hypoxia or repeated fluctuations between hyperoxia and hypoxia: relevance to clinical ROP. Mol Vis 10:512–520

    Google Scholar 

  55. Mancuso MR, Davis R, Norberg SM et al (2006) Rapid vascular regrowth in tumors after reversal of VEGF inhibition. J Clin Invest 116:2610–2621

    Article  PubMed  CAS  Google Scholar 

  56. Mantel I, Ambresin A, Zografos L (2006) Retinal angiomatous proliferation treated with a combination of intravitreal triamcinolone acetonide and photodynamic therapy with verteporfin. Eur J Ophthalmol 16:705–710

    PubMed  CAS  Google Scholar 

  57. Markomichelakis NN, Theodossiadis PG, Sfikakis PP (2005) Regression of neovascular age-related macular degeneration following infliximab therapy. Am J Ophthalmol 139:537–540

    Article  PubMed  Google Scholar 

  58. Martin G, Schlunck G, Hansen LL, Agostini HT (2004) Differential expression of angioregulatory factors in normal and CNV-derived human retinal pigment epithelium. Graefes Arch Clin Exp Ophthalmol 242:321–326

    Article  PubMed  CAS  Google Scholar 

  59. Maruotti N, Cantatore FP, Crivellato E et al (2006) Angiogenesis in rheumatoid arthritis. Histol Histopathol 21:557–566

    PubMed  CAS  Google Scholar 

  60. Marx J (2003) Angiogenesis. A boost for tumor starvation. Science 301:452–454

    Article  PubMed  CAS  Google Scholar 

  61. Matsuoka M, Ogata N, Otsuji T et al (2004) Expression of pigment epithelium derived factor and vascular endothelial growth factor in choroidal neovascular membranes and polypoidal choroidal vasculopathy. Br J Ophthalmol 88:809–815

    Article  PubMed  CAS  Google Scholar 

  62. Mayer RJ (2004) Two steps forward in the treatment of colorectal cancer. N Engl J Med 350:2406–2408

    Article  PubMed  CAS  Google Scholar 

  63. Miller KD, Chap LI, Holmes FA et al (2005) Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer. J Clin Oncol 23:792–799

    Article  PubMed  CAS  Google Scholar 

  64. Nicolo M, Ghiglione D, Lai S et al (2006) Occult with no classic choroidal neovascularization secondary to age-related macular degeneration treated by intravitreal triamcinolone and photodynamic therapy with verteporfin. Retina 26:58–64

    Article  PubMed  Google Scholar 

  65. Obata R, Inoue Y, Iriyama A et al (2007) Triamcinolone acetonide suppresses early proangiogenic response in RPE cells after photodynamic therapy in vitro. Br J Ophthalmol 91(1):100–104

    Article  PubMed  CAS  Google Scholar 

  66. Ogata N, Wada M, Otsuji T et al (2002) Expression of pigment epithelium-derived factor in normal adult rat eye and experimental choroidal neovascularization. Invest Ophthalmol Vis Sci 43:1168–1175

    PubMed  Google Scholar 

  67. Oh H, Takagi H, Takagi C et al (1999) The potential angiogenic role of macrophages in the formation of choroidal neovascular membranes. Invest Ophthalmol Vis Sci 40:1891–1898

    PubMed  CAS  Google Scholar 

  68. Ohno-Matsui K, Yoshida T, Uetama T et al (2003) Vascular endothelial growth factor upregulates pigment epithelium-derived factor expression via VEGFR-1 in human retinal pigment epithelial cells. Biochem Biophys Res Commun 303:962–967

    Article  PubMed  CAS  Google Scholar 

  69. Oshima Y, Oshima S, Nambu H et al (2004) Increased expression of VEGF in retinal pigmented epithelial cells is not sufficient to cause choroidal neovascularization. J Cell Physiol 201:393–400

    Article  PubMed  CAS  Google Scholar 

  70. Ostendorf T, Kunter U, Eitner F et al (1999) VEGF(165) mediates glomerular endothelial repair. J Clin Invest 104:913–923

    Article  PubMed  CAS  Google Scholar 

  71. Pietras K, Rubin K, Sjoblom T et al (2002) Inhibition of PDGF receptor signaling in tumor stroma enhances antitumor effect of chemotherapy. Cancer Res 62:5476–5484

    PubMed  CAS  Google Scholar 

  72. Rakic JM, Lambert V, Devy L et al (2003) Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization. Invest Ophthalmol Vis Sci 44:3186–3193

    Article  PubMed  Google Scholar 

  73. Relf M, LeJeune S, Scott PA et al (1997) Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis. Cancer Res 57:963–969

    PubMed  CAS  Google Scholar 

  74. Roberts WG, Palade GE (1995) Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci 108:2369–2379

    PubMed  CAS  Google Scholar 

  75. Rosenfeld PJ, Brown DM, Heier JS et al (2006) Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355:1419–1431

    Article  PubMed  CAS  Google Scholar 

  76. Ruiz-Moreno JM, Montero JA et al (2006) Photodynamic therapy and high-dose intravitreal triamcinolone to treat exudative age-related macular degeneration: 1-year outcome. Retina 26:602–612

    Article  PubMed  Google Scholar 

  77. Schmidt-Erfurth U, Schlotzer-Schrehard U, Cursiefen C et al (2003) Influence of photodynamic therapy on expression of vascular endothelial growth factor (VEGF), VEGF receptor 3, and pigment epithelium-derived factor. Invest Ophthalmol Vis Sci 44:4473–4480

    Article  PubMed  Google Scholar 

  78. Shi X, Semkova I, Muther PS et al (2006) Inhibition of TNF-alpha reduces laser-induced choroidal neovascularization. Exp Eye Res 83:1325–1334

    Article  PubMed  CAS  Google Scholar 

  79. Silletti S, Kessler T, Goldberg J et al (2001) Disruption of matrix metalloproteinase 2 binding to integrin alpha vbeta 3 by an organic molecule inhibits angiogenesis and tumor growth in vivo. Proc Natl Acad Sci USA 98:119–124

    Article  PubMed  CAS  Google Scholar 

  80. Smithen LM, Spaide RF (2004) Photodynamic therapy and intravitreal triamcinolone for a subretinal neovascularization in bilateral idiopathic juxtafoveal telangiectasis. Am J Ophthalmol 138:884–885

    Article  PubMed  CAS  Google Scholar 

  81. Spaide RF (2005) Etiology of late-age-related macular disease. In: Holz F, Spaide RF (eds) Medical retina. Springer, New York

    Google Scholar 

  82. Spaide RF (2006) Rationale for combination therapies for choroidal neovascularization. Am J Ophthalmol 141:149–156

    Article  PubMed  Google Scholar 

  83. Spaide RF, Sorenson J, Maranan L (2005) Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization. Ophthalmology 112:301–304

    Article  PubMed  Google Scholar 

  84. Spaide RF, Laud K, Fine HF et al (2006) Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration. Retina 26:383–390

    Article  PubMed  Google Scholar 

  85. Tatar O, Adam A, Shinoda K et al (2006) Expression of VEGF and PEDF in choroidal neovascular membranes following verteporfin photodynamic therapy. Am J Ophthalmol 142:95–104

    Article  PubMed  CAS  Google Scholar 

  86. Tsutsumi-Miyahara C, Sonoda KH, Egashira K et al (2004) The relative contributions of each subset of ocular infiltrated cells in experimental choroidal neovascularisation. Br J Ophthalmol 88:1217–1222

    Article  PubMed  CAS  Google Scholar 

  87. Uutela M, Wirzenius M, Paavonen K et al (2004) PDGF-D induces macrophage recruitment, increased interstitial pressure, and blood vessel maturation during angiogenesis. Blood 104:3198–3204

    Article  PubMed  CAS  Google Scholar 

  88. Winkler F, Kozin SV, Tong RT et al (2004) Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases. Cancer Cell 6:553–563

    PubMed  CAS  Google Scholar 

  89. Yan L, Anderson GM, DeWitte M, Nakada MT (2006) Therapeutic potential of cytokine and chemokine antagonists in cancer therapy. Eur J Cancer 42:793–802

    Article  PubMed  CAS  Google Scholar 

  90. Yoshiji H, Kuriyama S, Noguchi R et al (2006) Amelioration of liver fibrogenesis by dual inhibition of PDGF and TGF-beta with a combination of imatinib mesylate and ACE inhibitor in rats. Int J Mol Med 17:899–904

    PubMed  CAS  Google Scholar 

  91. Zhang SX, Wang JJ, Gao G et al (2006) Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy. J Mol Endocrinol 37:1–12

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Vitreous, Retina, and Macula Consultants of New York, and LuEsther T. Mertz Retinal Research Center, Manhattan Eye, Ear, and Throat Hospital, 460 Park Avenue, New York, NY, 10022, USA

    Richard F. Spaide MD (Prof.)

Authors
  1. Richard F. Spaide MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Ophthalmology, University of Bonn, Ernst-Abbe-Straße 2, 53127, Bonn, Germany

    Frank G. Holz MD (Professor of Ophthalmology) (Professor of Ophthalmology)

  2. Vitreous, Retina, and Macula Consultants of New York, and LuEsther T. Mertz Retinal Research Center, Manhattan Eye, Ear, and Throat Hospital, 460 Park Avenue, New York, NY, 10022, USA

    Richard F. Spaide MD (Assistent Clinical Professor) (Assistent Clinical Professor)

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Spaide, R.F. (2007). Combination Therapies for Choroidal Neovascularization. In: Holz, F.G., Spaide, R.F. (eds) Medical Retina. Essentials in Ophthalmology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-33672-3_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-33672-3_6

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-33671-6

  • Online ISBN: 978-3-540-33672-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation